Peter Stanich
Ohio State University Wexner Medical Center
Appearances
DateMay 8, 2023This symposium aims to highlight the immense (but sometimes underrated) importance of clinico-pathologic correlation for optimal patient management…Presenter
Ohio State University Wexner Medical Center
AGA GI Cancer Risk Assessment and Strategies for Management of Individuals at High Risk: What's New?
DateMay 6, 2023SOCIETY: AGAModerators
University of Colorado, Rocky Mountain Regional VAOhio State University Wexner Medical Center- DateMay 7, 2023Germline genetic testing is recommended for younger patients with idiopathic pancreatitis, but there is no consensus recommendation for those over age 35. We aimed to analyze the results of genetic testing for pancreatic genetic mutations using a large dataset including all ages…
Presenter
The Ohio State University Wexner Medical CenterSpeakers
Ohio State UniversityThe Ohio State University Medical CenterOhio State University Wexner Medical CenterOhio State University Wexner Medical Center 
DateMay 6, 2023SOCIETY: AGAModerators
Mayo ClinicOhio State University Wexner Medical Center- DateMay 21, 2024_BACKGROUND AND AIMS: _Preclinical data shows mTOR pathway upregulation in Familial Adenomatous Polyposis (FAP). Inhibition of this pathway by rapalogues, like rapamycin, suggests promising results, but poor drug bioavailability and toxicity limited effective use of these drugs in FAP trials…
Presenter
Cleveland ClinicSpeakers
University of MichiganOhio State University Wexner Medical CenterCleveland Clinic 
DateMay 6, 2025SOCIETY: AGAModerators
University of Colorado, Rocky Mountain Regional VAOhio State University Wexner Medical Center
